Bobak Azamian
2021
In 2021, Bobak Azamian earned a total compensation of $6.9M as President, Chief Executive Officer and Director at Tarsus Pharmaceuticals, a 174% increase compared to previous year.
Compensation breakdown
| Bonus | $269,500 |
|---|---|
| Option Awards | $6,029,589 |
| Salary | $550,000 |
| Other | $21,634 |
| Total | $6,870,723 |
Azamian received $6M in option awards, accounting for 88% of the total pay in 2021.
Azamian also received $269.5K in bonus, $550K in salary and $21.6K in other compensation.
Rankings
In 2021, Bobak Azamian's compensation ranked 1,797th out of 12,406 executives tracked by ExecPay. In other words, Azamian earned more than 85.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,797 out of 12,406 | 86th |
Division Manufacturing | 669 out of 5,492 | 88th |
Major group Chemicals And Allied Products | 251 out of 2,368 | 89th |
Industry group Drugs | 212 out of 2,089 | 90th |
Industry Biological Products, Except Diagnostic Substances | 59 out of 452 | 87th |
Source: SEC filing on May 2, 2022.
Azamian's colleagues
We found two more compensation records of executives who worked with Bobak Azamian at Tarsus Pharmaceuticals in 2021.